[Viral hepatitis--trends].
Viral hepatitis is a serious health problem all over the world. The aim of the study is to present the actual achievements in the therapeutically field and the general knowledge concerning the subject. Are presented the etiological agents of the acute and chronic hepatitis with the focus on hepatitis B and C, which has become a priority of WHO, with an incidence of the diseases of 360 billion/year for hepatitis B and an sub estimated level for C hepatitis. The most used drugs are presented and the therapeutical combination meant to decrease biological and virusological markers (ALAT, viral load) and to ameliorate the histological aspects of the liver. In conclusion, acute and chronic viral hepatitis represents a challenge for epidemiologists who try to stop the spread of the disease, but also for the infectious diseases specialists and gastroenterologists.
Manciuc
Carmen
C
Universitatea de Medicină şi Farmacie Gr.T. Popa Iaşi Facultatea de Medicină, Disciplina Boli Infecţioase.
Dorobăţ
Carmen
C
Filip-Ciubotaru
Florina-Mihaela
FM
D000998:Antiviral Agents / Q000627:therapeutic use; D006506:Hepatitis A / Q000453:epidemiology; D022362:Hepatitis A Vaccines / Q000008:administration & dosage; D006509:Hepatitis B / Q000453:epidemiology; D017325:Hepatitis B Vaccines / Q000008:administration & dosage; D019694:Hepatitis B, Chronic / Q000453:epidemiology; D006526:Hepatitis C / Q000453:epidemiology; D019698:Hepatitis C, Chronic / Q000453:epidemiology; D006525:Hepatitis, Viral, Human / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control; D006801:Humans; D015994:Incidence; D017063:Outcome Assessment, Health Care; D011159:Population Surveillance; D012307:Risk Factors
D000998:Antiviral Agents; D022362:Hepatitis A Vaccines; D017325:Hepatitis B Vaccines